by U.S. Right to Know By Lewis Kamb In mid-2016, as a federal moratorium still loomed over risky biomedical research, an ad hoc review committee of…
by U.S. Right to Know By Lewis Kamb In mid-2016, as a federal moratorium still loomed over risky biomedical research, an ad hoc review committee of…